SOLID FORMS

The disclosure is in part directed to crystalline forms of 5-(3,4-dichlorophenyl)-N-((1R,2R)-2-hydroxycyclohexyl)-6-(2,2,2-trifluoroethoxy)nicotinamide and pharmaceutical compositions thereof.

Saved in:
Bibliographic Details
Main Authors Hongyan, He, Dott, Pascal Jean Claude, Diodone, Ralph, Siyi, Jiang, Wyttenbach, Nicole, Grassmann, Olaf, Schwitter, Urs
Format Patent
LanguageEnglish
Published 12.09.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The disclosure is in part directed to crystalline forms of 5-(3,4-dichlorophenyl)-N-((1R,2R)-2-hydroxycyclohexyl)-6-(2,2,2-trifluoroethoxy)nicotinamide and pharmaceutical compositions thereof.
Bibliography:Application Number: US202318484722